The Angiogenesis Foundation

WHAT'S NEW

Anti-VEGF Agent Ramucirumab Approved to Help Treat mCRC

The U. S. Food and Drug Administration approved ramucirumab for use in combination with FOLFIRI for the treatment of patients with metastatic colorect Read More >

"(8) @OrayaTherapy , @TheAACE , Chinese Medical Association, and the Obesity Congress Alexandria - 3 months ago via Twitter

"(2) in no particular order: Karger Publishers, British Journal of Vascular Diseases, Wiley Publishing, Wichtig Publishing, @IntDiabetesFed , - 3 months ago via Twitter

"(5) @JPMedPub , @OphthoMag , @TheLancet , @JAMANetwork , Journal of Clinical Investigation, @NPGNews , Elsevier Vascular Pharmacology, @HRIA - 3 months ago via Twitter

"(3) European Assoc. for Vision & Eye Rsch, European Cancer Organisation, European Society of Ophtho, @VascularBiology , NY Acad. of Sciences - 3 months ago via Twitter

"(1) Thank you for attending or watching #Angio2015 #Worlds Collide! We would like to extend particular thanks to our Congress partners - 3 months ago via Twitter

"(6) @ICD10_Coding , @AmDiabetesAssn , @biodigitalhuman , @NYAMNYC , Springer Journals Angiogenesis, AHA/ASA Journals/Scientific Meetings - 3 months ago via Twitter

"Thank you for joining us for #Angio2015 #WorldsCollide! Tweet your comments and questions about the event to @angio_org - 3 months ago via Twitter

"Dr. Rybicki has a great example while discussing how people recognize each other by our faces http://t.co/pzojuKPwNC - 3 months ago via Twitter

Dr. William Li Delivers Keynote Address at the American Professional Wound Care Association National Clinical Conference

Dr. William Li, President and Medical Director of the Angiogenesis Foundation, gave the keynote address at the Read More >

People with Diabetes Have More Options: FDA Approves Anti-VEGF Agent Aflibercept for Diabetic Retinopathy

The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with Read More >

FDA Approves Anti-VEGF Agent Lenvatinib for Progressive Differentiated Thyroid Cancer

The U.S. Food and Drug Administration (FDA) has approved lenvatinib (Lenvima) to treat patients with progressive, differentiated thyroid cancer (DTC) Read More >

Antiangiogenic Agent Bevacizumab Gets EU Recommendation for Treating Cervical Cancer

The European Union's (EU) Committee for Medicinal Products for Human Use (CHMP) has recommended the use of bevacizumab (Avastin) in combination with s Read More >

Anti-VEGF Agent Aflibercept Approved for Treatment of Macular Edema Secondary to Retinal Vein Occlusion in the European Union

Anti-VEGF agent aflibercept (EYLEA®) has been approved by the European Commission for the treatment of visual impairment due to Macular Edema seconda Read More >

What’s Luck Got to Do with It?

Dr. William Li Featured on The Dr. Oz Show

What does luck have to do with cancer? A recently published Read More >

Big news for people with diabetes: Anti-VEGF agent ranibizumab approved to treat diabetic retinopathy to prevent vision loss

The U.S. Food and Drug Administration today expanded the approved use for ranibizumab injection 0.3 mg (Lucentis) to treat diabetic retinopathy (DR) i Read More >

Anti-VEGF Agent Lenvatinib Improves Progression Free Survival in Patients with Radioiodine-Refractory Thyroid Cancer

Lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet-de Read More >

Dr. William Li To Appear on The Dr. Oz Show

Consuming strawberries has been shown to play a role in the defense against cancer. Dr. William Li, President and Medical Director of the Angiogenesis Read More >

President of the Angiogenesis Foundation Will Serve as Co-Chair for iSPIES

President and Medical Director of the Angiogenesis Foundation Dr. William Li will serve as co-chair of the Summit for Perfusion Imaging and Excellence Read More >

ANGIO LIFE

Dr. Li shares 22 Cancer Fighting Tips with Dr. Oz

Dr. William Li joins Dr. Oz to share 22 ways to cut your risk of cancer risk by 50 percent. Read More >

Dr. William Li presents at TED

Dr. William Li presents “Can we eat to starve cancer?” at TED 2010 in Long Beach, CA. Read More >

November 6, 2014: For the second consecutive year, the Angiogenesis Foundation has received the highest rating from Charity Navigator, the prominent independent evaluator of charities. Read More >

May 20, 2014: “The Dr. Oz Show” features Dr. William Li who shares 3 all-natural breakthroughs that can reduce your risk of cancer. Read More >

April 23, 2014: The Bates-Jensen Wound Reach Foundation and the Angiogenesis Foundation announce Keith Brantly will run in the Wound Reach Foundation OUCH! Race. Read More >

February 7, 2014: Dr. William Li appears on “The Dr. Oz Show” to share 22 ways to cut your cancer risk by 50%. Read More >

January 21, 2014: The Angiogenesis Foundation, in collaboration with musician / activist Peter Gabriel, has launched the Do iT Yourself Health Revolution Read More >

November 7, 2013: The Angiogenesis Foundation receives highest rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability and transparency. Read More >

September 26, 2013: The Angiogenesis Foundation Launches Multimedia Campaigns for Saving Vision at the 13th Euretina Congress Read More >

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer at the European Cancer Congress 2013 Read More >

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Advancing Treatment of Wet Age-Related Macular Degeneration at the 13th Euretina Congress Read More >

July 16, 2013: The Angiogenesis Foundation Presents Concept of Antiangiogenic Foods at IFT 2013 Annual Meeting + Food Expo Read More >

June 4, 2013: Dr. William Li discusses the impact of drug shortages for cancer patients in USA Today. Read More >

June 3, 2013: Dr. William Li discusses recent developments for patients with metastatic thyroid cancer in USA Today. Read More >

May 31, 2013: The Angiogenesis Foundation releases Advancing Critical Pathways Forward in the Treatment of Colorectal and Kidney Cancer – White Papers at the ASCO Annual Meeting 2013. Read More >

May 30, 2013: The Angiogenesis Foundation Launches Science of Colorectal Cancer Patient Resource at ASCO Annual Meeting 2013. Read More >

May 7, 2013: The Angiogenesis Foundation releases white paper, “Critical Pathways Forward for Wet Age-Related Macular Degeneration in Asia Pacific.” Read More >

HEAR FROM THE EXPERTS

The “Best of Antiangiogenesis” is a series of webcasts, generated through Project ENABLE™, featuring presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies.

To view additional webcasts, click here

LEARN ABOUT DISEASE TREATMENTS

PUBLICATIONS

GREEN TEA

Our tea research is part of our Eat to Beat Cancer initiative, which is setting out to find foods and beverages that restore balance to the body's angiogenesis system. By purchasing this tea you are supporting our research and helping to advance the frontiers of cancer prevention.

Advocating Angiogenesis-based medicine, diets, and lifestyle.